CoChat

p53 and rapamycin are additive

Open access
Christy, Barbara, Demaria, Marco, Campisi, Judith, Huang, Jing, Jones, Diane, Dodds, Sherry G., Williams, Charnae, Hubbard, Gene, Livi, Carolina B., Gao, Xiaoli, Weintraub, Susan, Curiel, Tyler, Sharp, Z. Dave, Hasty, Paul · 2015 · Oncotarget
Cited by 37

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

// Barbara Christy 1,5,6,* , Marco Demaria 7,* , Judith Campisi 7 , Jing Huang 8 , Diane Jones 1 , Sherry G. Dodds 1 , Charnae Williams 1 , Gene Hubbard 2 , Carolina B. Livi 1,9 , Xiaoli Gao 3 , Susan Weintraub 3 , Tyler Curiel 4,5 , Z. Dave Sharp 1,5,6 and Paul Hasty 1,5,6 1 Departments of Molecular Medicine and Institute of Biotechnology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA 2 Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA 3 Department of Biochemistry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA 4 Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA 5 Cancer Therapy & Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA 6 Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA 7 Buck Institute for Research on Aging, Novato, CA, USA 8 Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA 9 Current address: Agilent Technologies, Inc., Santa Clara, CA, USA * These authors have contributed equally to this work Correspondence to: Paul Hasty, email: // Keywords : mTOR, p53, rapamycin, longevity, SASP Received : May 18, 2015 Accepted : June 14, 2015 Published : June 23, 2015 Abstract Mechanistic target of rapamycin (mTOR) is a kinase found in a complex (mTORC1) that enables macromolecular synthesis and cell growth and is implicated in cancer etiology. The rapamycin-FK506 binding protein 12 (FKBP12) complex allosterically inhibits mTORC1. In response to stress, p53 inhibits mTORC1 through a separate pathway involving cell signaling and amino acid sensing. Thus, these different mechanisms could be additive. Here we show that p53 improved the ability of rapamycin to: 1) extend mouse life span, 2) suppress ionizing radiation (IR)-induced senescence-associated secretory phenotype (SASP) and 3) increase the levels of amino acids and citric acid in mouse embryonic stem (ES) cells. This additive effect could have implications for cancer treatment since rapamycin and p53 are anti-oncogenic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.4602

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 37

Metadata

Authors
Christy, B., Demaria, M., Campisi, J., Huang, J., Jones, D., Dodds, S. G., Williams, C., Hubbard, G., Livi, C. B., Gao, X., Weintraub, S., Curiel, T., Sharp, Z. D., & Hasty, P.
Venue
Oncotarget
Published
2015-06-23
Volume
6
Issue
18
Pages
15802-15813
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1926632232
Cited by
37
References
20
FWCI
1.42
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: p53 and rapamycin are additive. https://app.cochat.ai/papers/10.18632/oncotarget.4602
The paper
Christy, B., Demaria, M., Campisi, J., Huang, J., Jones, D., Dodds, S. G., Williams, C., Hubbard, G., Livi, C. B., Gao, X., Weintraub, S., Curiel, T., Sharp, Z. D., & Hasty, P. (2015). p53 and rapamycin are additive. Oncotarget. https://doi.org/10.18632/oncotarget.4602

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.